Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations

References

1 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486–97. 10.1001/jama.285.19.2486Suche in Google Scholar

2 Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32: 1741–53. 10.1016/S0022-2275(20)41629-3Suche in Google Scholar

3 de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306. 10.1161/01.ATV.11.2.298Suche in Google Scholar

4 Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994; 5: 339–49. 10.1097/00041433-199410000-00005Suche in Google Scholar

5 Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 1997; 82: 3955–63. 10.1210/jc.82.12.3955Suche in Google Scholar

6 Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187–95. 10.1161/01.ATV.12.2.187Suche in Google Scholar

7 Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687–97. 10.1016/S0022-2275(20)35731-XSuche in Google Scholar

8 Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988; 260: 1917–21. 10.1001/jama.1988.03410130125037Suche in Google Scholar

9 Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241–53. 10.1016/0021-9150(94)90129-5Suche in Google Scholar

10 Wahi S, Gatzka CD, Sherrard B, Simpson H, Collins V, Dowse G, et al. Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: a case-control study of the Polynesian population of Western Samoa. J Cardiovasc Risk 1997; 4: 173–8. 10.1097/00043798-199706000-00003Suche in Google Scholar

11 Ruotolo G, Tettamanti C, Garancini MP, Ragogna F, Derosa G, Nardecchia L, et al. Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study. Atherosclerosis 1998; 140: 65–70. 10.1016/S0021-9150(98)00110-5Suche in Google Scholar

12 Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1–4. 10.1161/01.CIR.95.1.1Suche in Google Scholar

13 Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 2000; 20: 2140–7. 10.1161/01.ATV.20.9.2140Suche in Google Scholar

14 Hulthe J, Hulten LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2003; 52: 1612–4. 10.1016/S0026-0495(03)00313-5Suche in Google Scholar

15 Tan KC, Shiu SW, Wong Y. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus. Eur J Clin Invest 2003; 33: 301–6. 10.1046/j.1365-2362.2003.01132.xSuche in Google Scholar

16 Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001; 47: 266–74. 10.1093/clinchem/47.2.266Suche in Google Scholar

17 Friedwald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502. 10.1093/clinchem/18.6.499Suche in Google Scholar

18 Rajman I, Kendall MJ, Cramb R, Holder RL, Salih M, Gammage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 231–42. 10.1016/0021-9150(96)05881-9Suche in Google Scholar

19 Kazumi T, Kawaguchi A, Hozumi T, Nagao M, Iwahashi M, Hayakawa M, et al. Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men. Atherosclerosis 1999; 142: 113–9. 10.1016/S0021-9150(98)00201-9Suche in Google Scholar

20 Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97–104. 10.1016/S0022-2275(20)38178-5Suche in Google Scholar

21 Muniz N, Duncan D, Neyer G. Normal reference ranges for serum lipoproteins and their subfractions for the Lipoprint™ LDL system. Presented at the American Association of Clinical Chemistry 53th Annual meeting, Chicago, IL, Jul 29–Aug 2, 2001. Suche in Google Scholar

22 Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J Am Med Assoc 1996; 276: 875–81. 10.1001/jama.1996.03540110029028Suche in Google Scholar

23 Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69–75. 10.1161/01.CIR.95.1.69Suche in Google Scholar

24 Miller BD, Alderman EL, Haskell WL, Fair JM, Krauss RM. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation 1996; 94: 2146–53. 10.1161/01.CIR.94.9.2146Suche in Google Scholar

25 Walldius G, Jungner I, Holme I, Aastveit A, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026–33. 10.1016/S0140-6736(01)07098-2Suche in Google Scholar

26 Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, et al. Apolipoproteins vs. lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361: 777–80. 10.1016/S0140-6736(03)12663-3Suche in Google Scholar

27 Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001; 135: 447–59. 10.7326/0003-4819-135-6-200109180-00014Suche in Google Scholar PubMed

28 Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495–506. 10.1161/01.CIR.82.2.495Suche in Google Scholar

29 Tan CE, Foster L, Caslake MJ, Bedford D, Watson TD, McConnell M, et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol 1995; 15: 1839–48. 10.1161/01.ATV.15.11.1839Suche in Google Scholar PubMed

30 Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 1993; 13: 815–25. 10.1161/01.ATV.13.6.815Suche in Google Scholar PubMed

31 Watson TD, Caslake MJ, Freeman DJ, Griffin BA, Hinnie J, Packard CJ, et al. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb 1994; 14: 902–10. 10.1161/01.ATV.14.6.902Suche in Google Scholar

32 Koba S, Hirano T, Yoshino G, Sakai K, Sakaue T, Adachi M, et al. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 2002; 160: 249–56. 10.1016/S0021-9150(01)00580-9Suche in Google Scholar

33 Hirano T, Oi K, Sakai S, Kashiwazaki K, Adachi M, Yoshino G. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia. Atherosclerosis 1998; 141: 77–85. 10.1016/S0021-9150(98)00150-6Suche in Google Scholar

34 Makimattila S, Liu ML, Vakkilainen J, Schlenzka A, Lahdenpera S, Syvanne M, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999; 22: 973–81. 10.2337/diacare.22.6.973Suche in Google Scholar

35 Scheffer PG, Bos G, Volwater HG, Dekker JM, Heine RJ, Teerlink T. Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in type 2 diabetic patients. Diabet Med 2003; 20: 563–7. 10.1046/j.1464-5491.2003.00975.xSuche in Google Scholar

36 Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102–6. 10.2337/diabetes.51.10.3102Suche in Google Scholar

37 Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793–5. 10.1016/S0140-6736(94)92346-9Suche in Google Scholar

38 Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993; 94: 350–6. 10.1016/0002-9343(93)90144-ESuche in Google Scholar

39 de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306. 10.1161/01.ATV.11.2.298Suche in Google Scholar

40 Dejager S, Bruckert E, Chapman MJ. Dense low-density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 1993; 34: 295–308. 10.1016/S0022-2275(20)40756-4Suche in Google Scholar

41 Erbey JR, Robbins D, Forrest KY, Orchard TJ. Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population. Metabolism 1999; 48: 531–4. 10.1016/S0026-0495(99)90116-6Suche in Google Scholar

42 de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306. 10.1161/01.ATV.11.2.298Suche in Google Scholar

43 Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic as-pects. Diabetes Metab 1999; 25: 199–211. Suche in Google Scholar

44 de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. Arterioscler Thromb 1993; 13: 712–9. 10.1161/01.ATV.13.5.712Suche in Google Scholar

45 Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124: 261–71. 10.1016/0021-9150(96)05842-XSuche in Google Scholar